📰 Segments Profiled News
Page 32 - Segments Profiled News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Segments Profiled. Real-time updates on events, politics, business and more.
February 7, 2023
The global Dementia Management Market is expected to garner a market value of US$ 35 Million in 2023 and is expected to accumulate a market value of US$ 75.56 Millionby registering a CAGR of8% in the forecast period 2023 to 2033. The market for Dementia Management registered a CAGR of 5% in the historical period 201...
February 6, 2023
During the forecast period 2023-2033, the Chronic Granulomatous Disease (CGD) Management Market is expected to grow at a value of 4.9% CAGR, according to Future Market Insights. By the year 2033, the global market for Chronic Granulomatous disease (CGD) management is expected to rise up to a market valuation of US$...
February 6, 2023
The global next generation immunotherapies market is estimated to exceed a spectacular valuation of US$ 268.84 billion in 2033, with a compound annual growth rate (CAGR) of 7.5% projected from 2023 to 2033. The vast majority of present immunotherapies, such as checkpoint inhibitors, seek to enhance the immune system...
February 6, 2023
During the forecast period 2023-2033, the IgA Nephropathy Market is expected to grow at a value of 7.5% CAGR, according to Future Market Insights. By the year 2033, the global market for IgA nephropathy is expected to rise up to a market valuation of US$ 85 Billion.Key factors such as high prevalence of kidney disea...
February 6, 2023
The global opioid use disorder treatment market size is expected to attain an impressive valuation of US$ 3.07 billion in 2023 and is projected to reach US$ 8.4 billion by 2033, expanding at a CAGR of 10.5% during the forecast period. The drug abuse treatment providers and manufacturers primarily focus on creating a...
February 6, 2023
The global Prinzmetal Angina Therapeutics Market is expected to surpass an impressive valuation of US$ 10.7 Billion in 2023 and is projected to reach US$ 17.2 Billion by 2033, trailing a CAGR of 4.85%.The development of biosimilars and biobetters, growth in diabetic and hypertension population due to unhealthy lifes...
February 3, 2023
According to a recent study published by Future Market Insights, the market for oncolytic virus cancer therapy is forecast to reach a valuation of US$ 22.86 Million by 2023-end, and will eventually reach US$ 250 Million by 2033, growing at an astronomical CAGR of 27%. Governments in various emerging economies have c...
February 2, 2023
The global Cytokine Release Syndrome Management Market is expected to be worth US$ 23.32 billion in 2023, growing at a 6.7% CAGR between 2023 and 2033. In the coming years, the market for CRS management is expected to grow due to an increase in the number of autoimmune diseases and cancers.The development of novel t...
February 2, 2023
The global Fucosidosis Therapeutics Market is expected to garner a market value of US$ 10 Million in 2023 and is expected to accumulate a market value of US$ 17.91 Million by registering a CAGR of 6% in the forecast period 2023 to 2033. The market for Fucosidosis Therapeutics registered a CAGR of 4% in the historica...
February 2, 2023
The global disposable insulin-delivery device market is expected to be worth US$ 14,585.6 million in 2022, rising at a 7.7% CAGR to US$ 32,887.5 million between 2022 and 2032. The increase is attributable to an increase in diabetes-related health spending in emerging nations.Diabetes is one of the most chronic and l...